Drug Patents owned by Glaxosmithkline Cons

1. Drug name - FLONASE SENSIMIST ALLERGY RELIEF

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9320862 GLAXOSMITHKLINE CONS Fluid dispensing device Nov, 2024

(2 years from now)

US8752543 GLAXOSMITHKLINE CONS Fluid dispensing device Apr, 2026

(3 years from now)

US8062264 GLAXOSMITHKLINE CONS Fluid dispensing device Apr, 2026

(3 years from now)

US8347879 GLAXOSMITHKLINE CONS Fluid dispensing device Jul, 2028

(5 years from now)

US8147461 GLAXOSMITHKLINE CONS Fluid dispensing device Oct, 2028

(6 years from now)

Drugs and Companies using FLUTICASONE FUROATE ingredient

Treatment: NA

Dosage: SPRAY, METERED;NASAL

More Information on Dosage
Strength Dosage Availability
0.0275MG/SPRAY SPRAY, METERED;NASAL Over the counter

availability in other generic markets.

Click on the highlighted region to filter.